Improving transparency in the financial aspects of Cancer care involves multiple steps. One approach is to ensure that research funding sources and drug pricing structures are openly disclosed. Additionally, non-profit organizations and patient advocacy groups can play a crucial role in monitoring and reporting on these issues. Greater transparency can help build trust and ensure that financial motivations do not overshadow patient care.